Literature DB >> 18334488

Fat-specific protein 27 regulates storage of triacylglycerol.

Pernille Keller1, John T Petrie, Paul De Rose, Isabelle Gerin, Wendy S Wright, Shian-Huey Chiang, Anders R Nielsen, Christian P Fischer, Bente K Pedersen, Ormond A MacDougald.   

Abstract

FSP27 (fat-specific protein 27) is a member of the cell death-inducing DNA fragmentation factor-alpha-like effector (CIDE) family. Although Cidea and Cideb were initially characterized as activators of apoptosis, recent studies have demonstrated important metabolic roles for these proteins. In this study, we investigated the function of another member of this family, FSP27 (Cidec), in apoptosis and adipocyte metabolism. Although overexpression of FSP27 is sufficient to increase apoptosis of 293T and 3T3-L1 cells, more physiological levels of expression stimulate spontaneous lipid accumulation in several cell types without induction of adipocyte genes. Increased triacylglycerol is likely due to decreased beta-oxidation of nonesterified fatty acids. Altered flux of fatty acids into triacylglycerol may be a direct effect of FSP27 function, which is localized to lipid droplets in 293T cells and 3T3-L1 adipocytes. Stable knockdown of FSP27 during adipogenesis of 3T3-L1 cells substantially decreases lipid droplet size, increases mitochondrial and lipid droplet number, and modestly increases glucose uptake and lipolysis. Expression of FSP27 in subcutaneous adipose tissue of a human diabetes cohort decreases with total fat mass but is not associated with measures of insulin resistance (e.g. homeostasis model assessment). Together, these data indicate that FSP27 binds to lipid droplets and regulates their enlargement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18334488      PMCID: PMC2386939          DOI: 10.1074/jbc.M708323200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Cidea-deficient mice have lean phenotype and are resistant to obesity.

Authors:  Zhihong Zhou; Shen Yon Toh; Zhengming Chen; Ke Guo; Chee Peng Ng; Sathivel Ponniah; Sheng-Cai Lin; Wanjin Hong; Peng Li
Journal:  Nat Genet       Date:  2003-08-10       Impact factor: 38.330

Review 2.  Role of PAT proteins in lipid metabolism.

Authors:  C Londos; C Sztalryd; J T Tansey; A R Kimmel
Journal:  Biochimie       Date:  2005-01       Impact factor: 4.079

3.  In-depth analysis of the adipocyte proteome by mass spectrometry and bioinformatics.

Authors:  Jun Adachi; Chanchal Kumar; Yanling Zhang; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2007-04-04       Impact factor: 5.911

4.  Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice.

Authors:  J Martinez-Botas; J B Anderson; D Tessier; A Lapillonne; B H Chang; M J Quast; D Gorenstein; K H Chen; L Chan
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

5.  Adipocyte differentiation-related protein in human skeletal muscle: relationship to insulin sensitivity.

Authors:  Susan A Phillips; Charles C Choe; Theodore P Ciaraldi; Andrew S Greenberg; Alice P S Kong; Sunita C Baxi; Louis Christiansen; Sunder R Mudaliar; Robert R Henry
Journal:  Obes Res       Date:  2005-08

6.  Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet.

Authors:  Wataru Motomura; Mitsutaka Inoue; Takaaki Ohtake; Nubuhiko Takahashi; Miho Nagamine; Satoshi Tanno; Yutaka Kohgo; Toshikatsu Okumura
Journal:  Biochem Biophys Res Commun       Date:  2005-12-28       Impact factor: 3.575

7.  A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-alpha)-like effector A (CIDEA) in adipocyte lipolysis and obesity.

Authors:  Elisabet Arvidsson Nordström; Mikael Rydén; Emma C Backlund; Ingrid Dahlman; Maria Kaaman; Lennart Blomqvist; Barbara Cannon; Jan Nedergaard; Peter Arner
Journal:  Diabetes       Date:  2005-06       Impact factor: 9.461

8.  LSDP5 is a PAT protein specifically expressed in fatty acid oxidizing tissues.

Authors:  Knut Tomas Dalen; Tuva Dahl; Elin Holter; Borghild Arntsen; Constantine Londos; Carole Sztalryd; Hilde I Nebb
Journal:  Biochim Biophys Acta       Date:  2006-12-08

9.  PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.

Authors:  Susan E Schadinger; Nancy L R Bucher; Barbara M Schreiber; Stephen R Farmer
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-01-11       Impact factor: 4.310

10.  Relations of adipose tissue CIDEA gene expression to basal metabolic rate, energy restriction, and obesity: population-based and dietary intervention studies.

Authors:  Anders Gummesson; Margareta Jernås; Per-Arne Svensson; Ingrid Larsson; Camilla A M Glad; Erik Schéle; Lena Gripeteg; Kajsa Sjöholm; Theodore C Lystig; Lars Sjöström; Björn Carlsson; Björn Fagerberg; Lena M S Carlsson
Journal:  J Clin Endocrinol Metab       Date:  2007-09-25       Impact factor: 5.958

View more
  92 in total

Review 1.  The role of lipid droplets in metabolic disease in rodents and humans.

Authors:  Andrew S Greenberg; Rosalind A Coleman; Fredric B Kraemer; James L McManaman; Martin S Obin; Vishwajeet Puri; Qing-Wu Yan; Hideaki Miyoshi; Douglas G Mashek
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  Differential regulation of CIDEA and CIDEC expression by insulin via Akt1/2- and JNK2-dependent pathways in human adipocytes.

Authors:  Minoru Ito; Michiaki Nagasawa; Naoki Omae; Tomohiro Ide; Yunike Akasaka; Koji Murakami
Journal:  J Lipid Res       Date:  2011-06-02       Impact factor: 5.922

3.  Liver-specific ablation of Krüppel-associated box-associated protein 1 in mice leads to male-predominant hepatosteatosis and development of liver adenoma.

Authors:  Karolina Bojkowska; Fabio Aloisio; Marco Cassano; Adamandia Kapopoulou; Francesca Santoni de Sio; Nadine Zangger; Sandra Offner; Cristina Cartoni; Charles Thomas; Simon Quenneville; Kai Johnsson; Didier Trono
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

4.  Regulation of fat specific protein 27 by isoproterenol and TNF-α to control lipolysis in murine adipocytes.

Authors:  Srijana Ranjit; Emilie Boutet; Pallavi Gandhi; Matthieu Prot; Yoshikazu Tamori; Anil Chawla; Andrew S Greenberg; Vishwajeet Puri; Michael P Czech
Journal:  J Lipid Res       Date:  2010-11-20       Impact factor: 5.922

5.  Effector T cells require fatty acid metabolism during murine graft-versus-host disease.

Authors:  Craig A Byersdorfer; Victor Tkachev; Anthony W Opipari; Stefanie Goodell; Jacob Swanson; Stacy Sandquist; Gary D Glick; James L M Ferrara
Journal:  Blood       Date:  2013-09-17       Impact factor: 22.113

Review 6.  The role of miRNAs in cardiovascular disease risk factors.

Authors:  Joy N Jones Buie; Andrew J Goodwin; James A Cook; Perry V Halushka; Hongkuan Fan
Journal:  Atherosclerosis       Date:  2016-09-22       Impact factor: 5.162

7.  Fat-specific protein 27 undergoes ubiquitin-dependent degradation regulated by triacylglycerol synthesis and lipid droplet formation.

Authors:  Zongqian Nian; Zhiqi Sun; Luxin Yu; Shen Yon Toh; Jianli Sang; Peng Li
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

8.  CDP-DAG synthase 1 and 2 regulate lipid droplet growth through distinct mechanisms.

Authors:  Yanqing Xu; Hoi Yin Mak; Ivan Lukmantara; Yang E Li; Kyle L Hoehn; Xun Huang; Ximing Du; Hongyuan Yang
Journal:  J Biol Chem       Date:  2019-09-23       Impact factor: 5.157

9.  De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis.

Authors:  Mohamed Sabry Hamza; Sebastian Pott; Vinsensius B Vega; Jane S Thomsen; Gopalan Srinivasan Kandhadayar; Patrick Wei Pern Ng; Kuo Ping Chiu; Sven Pettersson; Chia Lin Wei; Yijun Ruan; Edison T Liu
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

10.  Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC.

Authors:  Oscar Rubio-Cabezas; Vishwajeet Puri; Incoronata Murano; Vladimir Saudek; Robert K Semple; Satya Dash; Caroline S S Hyden; William Bottomley; Corinne Vigouroux; Jocelyne Magré; Philippa Raymond-Barker; Peter R Murgatroyd; Anil Chawla; Jeremy N Skepper; V Krishna Chatterjee; Sara Suliman; Ann-Marie Patch; Anil K Agarwal; Abhimanyu Garg; Inês Barroso; Saverio Cinti; Michael P Czech; Jesús Argente; Stephen O'Rahilly; David B Savage
Journal:  EMBO Mol Med       Date:  2009-08       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.